Soleus Capital Management, L.P. 13F holdings, Q4 2024
Holdings as of December 31, 2024 · filings on SEC EDGAR · latest filing →
Soleus Capital Management, L.P. disclosed 80 US equity positions worth $1.3bn in its Q4 2024 13F filing. The largest position was NVCR at 6.2% of the reported book, followed by TGTX and BMRN. Against the Q3 2024 filing, it opened 12 new positions, added to 21 and reduced 13 among the top 50 holdings.
What did Soleus Capital Management, L.P. own in Q4 2024? Top 50 positions
| # | Stock | Sector | Weight | Value | Shares | Δ shares | vs Q3 2024 |
|---|---|---|---|---|---|---|---|
| 1 | NVCR NOVOCURE LTD | Healthcare | 6.2% | $81.6m | 2,739,704 | – | new |
| 2 | TGTX TG THERAPEUTICS INC | Healthcare | 6.1% | $80.7m | 2,681,242 | 6% | added |
| 3 | BMRN BIOMARIN PHARMACEUTICAL INC | Healthcare | 5.0% | $65.8m | 1,001,400 | – | new |
| 4 | KRYS KRYSTAL BIOTECH INC | Healthcare | 4.2% | $56.1m | 358,379 | 65% | added |
| 5 | GRFS GRIFOLS S A | Healthcare | 3.7% | $49.1m | 6,605,425 | 46% | added |
| 6 | AXGN AXOGEN INC | Healthcare | 3.7% | $48.7m | 2,955,943 | -2% | reduced |
| 7 | IOVA IOVANCE BIOTHERAPEUTICS INC | Healthcare | 3.7% | $48.5m | 6,560,000 | -23% | reduced |
| 8 | TEVA TEVA PHARMACEUTICAL INDS LTD | Healthcare | 3.5% | $46.1m | 2,093,000 | – | new |
| 9 | 430 TERNS PHARMACEUTICALS INC | 3.4% | $45.1m | 8,142,500 | 31% | added | |
| 10 | ORGO ORGANOGENESIS HLDGS INC | Healthcare | 3.0% | $40.0m | 12,484,876 | 5% | added |
| 11 | NRIX NURIX THERAPEUTICS INC | Healthcare | 3.0% | $39.6m | 2,102,833 | 97% | added |
| 12 | UTHR UNITED THERAPEUTICS CORP DEL | Healthcare | 2.9% | $38.6m | 109,394 | 7% | added |
| 13 | CELC CELCUITY INC | Healthcare | 2.5% | $33.6m | 2,565,087 | 106% | added |
| 14 | SNDX SYNDAX PHARMACEUTICALS INC | Healthcare | 2.5% | $32.9m | 2,492,000 | 128% | added |
| 15 | JSPR JASPER THERAPEUTICS INC | 2.4% | $32.0m | 1,494,420 | 11% | added | |
| 16 | IART INTEGRA LIFESCIENCES HLDGS C | Healthcare | 2.2% | $28.9m | 1,276,000 | – | new |
| 17 | NPCE NEUROPACE INC | 2.1% | $27.2m | 2,433,168 | 0% | held | |
| 18 | AZN ASTRAZENECA PLC | Healthcare | 2.0% | $26.8m | 409,000 | – | new |
| 19 | CCCC C4 THERAPEUTICS INC | Healthcare | 1.9% | $25.1m | 6,978,942 | 6% | added |
| 20 | QDEL QUIDELORTHO CORP | Healthcare | 1.8% | $24.4m | 547,082 | -20% | reduced |
| 21 | INSM INSMED INC | Healthcare | 1.7% | $22.1m | 320,272 | 958% | added |
| 22 | IKT INHIBIKASE THERAPEUTICS INC | 1.6% | $20.6m | 6,325,000 | – | new | |
| 23 | ASND ASCENDIS PHARMA A/S | Healthcare | 1.5% | $19.8m | 144,000 | – | new |
| 24 | RIGL RIGEL PHARMACEUTICALS INC | 1.4% | $19.0m | 1,130,679 | 21% | added | |
| 25 | PRAX PRAXIS PRECISION MEDICINES I | Healthcare | 1.4% | $18.7m | 243,540 | -6% | reduced |
| 26 | ALNY ALNYLAM PHARMACEUTICALS INC | Healthcare | 1.4% | $18.1m | 76,800 | 29% | added |
| 27 | ADPT ADAPTIVE BIOTECHNOLOGIES COR | Healthcare | 1.4% | $17.9m | 2,983,142 | 168% | added |
| 28 | EDAP TMS S A | 1.2% | $16.2m | 7,309,254 | 0% | held | |
| 29 | TAK TAKEDA PHARMACEUTICAL CO LTD | Healthcare | 1.2% | $15.6m | 1,180,000 | 136% | added |
| 30 | PHVS PHARVARIS N V | 1.2% | $15.6m | 814,652 | 36% | added | |
| 31 | SU6 SURMODICS INC | 1.2% | $15.6m | 394,060 | -38% | reduced | |
| 32 | SEPN SEPTERNA INC | 1.2% | $15.5m | 675,409 | – | new | |
| 33 | MERUS N V | 1.0% | $13.1m | 312,321 | -22% | reduced | |
| 34 | OFIX ORTHOFIX MED INC | Healthcare | 0.9% | $12.0m | 686,374 | 13% | added |
| 35 | ANIP ANI PHARMACEUTICALS INC | Healthcare | 0.9% | $11.3m | 205,294 | -24% | reduced |
| 36 | VSTM VERASTEM INC | Healthcare | 0.9% | $11.3m | 2,184,026 | -23% | reduced |
| 37 | PTGX PROTAGONIST THERAPEUTICS INC | Healthcare | 0.8% | $10.6m | 275,000 | – | new |
| 38 | DCTH DELCATH SYS INC | 0.7% | $9.6m | 801,000 | – | new | |
| 39 | CGON CG ONCOLOGY INC | Healthcare | 0.7% | $9.4m | 328,585 | -4% | reduced |
| 40 | ACLXGBX ARCELLX INC | 0.7% | $9.3m | 121,031 | 30% | added | |
| 41 | LLY ELI LILLY & CO | Healthcare | 0.7% | $9.0m | 11,658 | -40% | reduced |
| 42 | RVMD REVOLUTION MEDICINES INC | Healthcare | 0.7% | $8.8m | 201,084 | -71% | reduced |
| 43 | THERATECHNOLOGIES INC | 0.7% | $8.7m | 4,801,376 | 0% | held | |
| 44 | NUVALENT INC | 0.6% | $8.2m | 104,357 | 40% | added | |
| 45 | PCVX VAXCYTE INC | Healthcare | 0.6% | $8.1m | 99,050 | 266% | added |
| 46 | EOLS EVOLUS INC | Healthcare | 0.6% | $7.7m | 697,158 | -33% | reduced |
| 47 | IMUX IMMUNIC INC | Healthcare | 0.6% | $7.3m | 7,293,007 | 0% | held |
| 48 | SRRK SCHOLAR ROCK HLDG CORP | Healthcare | 0.5% | $7.2m | 167,543 | – | new |
| 49 | CSTL CASTLE BIOSCIENCES INC | Healthcare | 0.5% | $6.7m | 252,917 | -62% | reduced |
| 50 | MYO MYOMO INC | 0.4% | $5.8m | 900,000 | – | new |
Weights are shares of the reported long US equity book (options excluded). Values are as filed, normalised to whole dollars. Share changes compare against the immediately preceding filing only.